(secondQuint)Analysis of Adherence in Subjects Undergoing Differin Gel, 0.

1% Treatment of Moderate to Severe Acne Vulgaris.

 Subjects will be enrolled and randomized in a 1:1:1:1 ratio to one of four treatment intervention groups.

 All Subjects will be treated once-daily for 12 weeks with Differin(R) Gel, 0.

1%.

 The four intervention groups were designated according to follow-up strategies as follows: - More frequent than normal office visits - Electronic reminders (voice, e-mail, text messages) - Parental involvement/intervention reminders - No intervention or reminders.

 Analysis of Adherence in Subjects Undergoing Differin Gel, 0.

1% Treatment of Moderate to Severe Acne Vulgaris@highlight

The primary objective of this study is to investigate potential differences between four treatment intervention groups in the adherence to treatment with Differin(R) Gel, 0.

1%.

 Differin is approved by the Food and Drug Administration (FDA) to treat acne.

